Phase I/Ib Trial of TIraGolumab, AtEzolizumab, and RadScopal Radiation in Patients With Advanced Solid Malignancies (TIGER)
Clinical trial NCT06760481 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06760481
- Sponsor
- M.D. Anderson Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-13
- Primary completion
- 2028-09-15
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.